Guedes JR, Ferreira PA, Costa J, Laranjo M, Pinto MJ, Reis T, et al
You stay here for the remainder of your treatment, whether that is months or years
Some areas, such as dementia, addiction, asthma, joint pain and broader anti-inflammatory effects, remain promising but still need more high-quality clinical trials
Clinical trials confirmed no effect on serum IGF-1 levels, no negative effect on carbohydrate metabolism, and no anti-AOD-9604 antibodies detected in any participants
Related Blogs: Bay Medical
The study found that while cardioprotective glucose-lowering therapies overall were not significantly associated with reduced dementia risk, GLP-1 receptor agonists specifically were linked to a statistically significant reduction in all-cause dementia